FI20065757A0 - Användning av beta-laktamas - Google Patents

Användning av beta-laktamas

Info

Publication number
FI20065757A0
FI20065757A0 FI20065757A FI20065757A FI20065757A0 FI 20065757 A0 FI20065757 A0 FI 20065757A0 FI 20065757 A FI20065757 A FI 20065757A FI 20065757 A FI20065757 A FI 20065757A FI 20065757 A0 FI20065757 A0 FI 20065757A0
Authority
FI
Finland
Prior art keywords
lactamase
beta
Prior art date
Application number
FI20065757A
Other languages
English (en)
Finnish (fi)
Other versions
FI119678B (sv
FI20065757A (sv
Inventor
Pertti Koski
Tapio Korkolainen
Kristiina Raatesalmi
Original Assignee
Ipsat Therapies Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsat Therapies Oy filed Critical Ipsat Therapies Oy
Publication of FI20065757A0 publication Critical patent/FI20065757A0/sv
Priority to FI20065757A priority Critical patent/FI119678B/sv
Priority to CNA2007800441657A priority patent/CN101563099A/zh
Priority to KR1020097013077A priority patent/KR20090085122A/ko
Priority to CA002670440A priority patent/CA2670440A1/en
Priority to JP2009538736A priority patent/JP2010511020A/ja
Priority to EP07848160A priority patent/EP2086570A1/en
Priority to BRPI0718880-3A priority patent/BRPI0718880A2/pt
Priority to AU2007327472A priority patent/AU2007327472A1/en
Priority to RU2009124460/15A priority patent/RU2009124460A/ru
Priority to PCT/FI2007/050627 priority patent/WO2008065247A1/en
Publication of FI20065757A publication Critical patent/FI20065757A/sv
Application granted granted Critical
Publication of FI119678B publication Critical patent/FI119678B/sv
Priority to US12/473,532 priority patent/US20090311234A1/en
Priority to NO20092433A priority patent/NO20092433L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/02—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amides (3.5.2)
    • C12Y305/02006—Beta-lactamase (3.5.2.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI20065757A 2006-11-28 2006-11-28 Användning av beta-laktamas FI119678B (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FI20065757A FI119678B (sv) 2006-11-28 2006-11-28 Användning av beta-laktamas
BRPI0718880-3A BRPI0718880A2 (pt) 2006-11-28 2007-11-21 Uso da beta-lactamase
RU2009124460/15A RU2009124460A (ru) 2006-11-28 2007-11-21 Применение бета-лактамазы
CA002670440A CA2670440A1 (en) 2006-11-28 2007-11-21 Use of beta-lactamase
JP2009538736A JP2010511020A (ja) 2006-11-28 2007-11-21 ベータ−ラクタマーゼの使用
EP07848160A EP2086570A1 (en) 2006-11-28 2007-11-21 Use of beta-lactamase
CNA2007800441657A CN101563099A (zh) 2006-11-28 2007-11-21 β-内酰胺酶的用途
AU2007327472A AU2007327472A1 (en) 2006-11-28 2007-11-21 Use of beta-lactamase
KR1020097013077A KR20090085122A (ko) 2006-11-28 2007-11-21 베타 락타마제의 용도
PCT/FI2007/050627 WO2008065247A1 (en) 2006-11-28 2007-11-21 Use of beta-lactamase
US12/473,532 US20090311234A1 (en) 2006-11-28 2009-05-28 Use of beta-lactamase
NO20092433A NO20092433L (no) 2006-11-28 2009-06-26 Anvendelse av beta-laktamase

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20065757 2006-11-28
FI20065757A FI119678B (sv) 2006-11-28 2006-11-28 Användning av beta-laktamas

Publications (3)

Publication Number Publication Date
FI20065757A0 true FI20065757A0 (sv) 2006-11-28
FI20065757A FI20065757A (sv) 2008-05-29
FI119678B FI119678B (sv) 2009-02-13

Family

ID=37482569

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20065757A FI119678B (sv) 2006-11-28 2006-11-28 Användning av beta-laktamas

Country Status (12)

Country Link
US (1) US20090311234A1 (sv)
EP (1) EP2086570A1 (sv)
JP (1) JP2010511020A (sv)
KR (1) KR20090085122A (sv)
CN (1) CN101563099A (sv)
AU (1) AU2007327472A1 (sv)
BR (1) BRPI0718880A2 (sv)
CA (1) CA2670440A1 (sv)
FI (1) FI119678B (sv)
NO (1) NO20092433L (sv)
RU (1) RU2009124460A (sv)
WO (1) WO2008065247A1 (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014201082B2 (en) * 2010-05-24 2015-04-30 Synthetic Biologics, Inc. Modified beta-lactamases and methods and uses related thereto
FI20105572A0 (sv) * 2010-05-24 2010-05-24 Prevab R Lcc Modifierad beta-laktamas och förfaranden och användningar relaterade därtill
EA028342B1 (ru) 2011-09-09 2017-11-30 Мерк Шарп И Доум Корп. Способы лечения пневмонии
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140274994A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Stabilizing ceftolozane
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274996A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Tazobactam and ceftolozane antibiotic compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
EP3132033B1 (en) 2014-04-17 2019-10-30 Synthetic Biologics, Inc. Beta-lactamases with improved properties for therapy
JP6803328B2 (ja) * 2014-08-28 2021-01-06 シンセティック バイオロジクス，インコーポレイテッド 大腸菌ベースでのベータラクタマーゼ生産
JP6672277B2 (ja) 2014-10-08 2020-04-01 シンセティック・バイオロジクス・インコーポレイテッド ベータラクタマーゼ製剤およびその使用
FR3027307B1 (fr) * 2014-10-16 2016-11-04 Azurrx Sas Molecule proteique hybride apte a inhiber au moins un antibiotique et composition pharmaceutique la comportant
WO2016105498A1 (en) 2014-12-23 2016-06-30 Synthetic Biologics, Inc. Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
CN107530406B (zh) 2015-02-23 2021-10-22 合成生物制品有限公司 用于保护肠微生物群系的与抗生素一起使用的碳青霉烯酶
AU2016229976B2 (en) 2015-03-06 2021-11-11 Theriva Biologics, Inc. Safe and effective beta-lactamase dosing for microbiome protection
US11185555B2 (en) 2016-04-11 2021-11-30 Noah James Harrison Method to kill pathogenic microbes in a patient
EP3474885B8 (en) * 2016-06-28 2023-06-21 Theriva Biologics, Inc. Microbiome protection from oral antibiotics
CN111511368B (zh) * 2017-12-25 2023-05-09 湘北威尔曼制药股份有限公司 治疗耐药性鲍曼不动杆菌感染的含哌拉西林钠和舒巴坦钠的组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2843302B1 (fr) * 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
CN101257892B (zh) * 2005-05-18 2013-01-02 达沃尔泰拉公司 吸附剂的结肠递送

Also Published As

Publication number Publication date
CA2670440A1 (en) 2008-06-05
EP2086570A1 (en) 2009-08-12
FI119678B (sv) 2009-02-13
NO20092433L (no) 2009-06-26
WO2008065247A1 (en) 2008-06-05
US20090311234A1 (en) 2009-12-17
BRPI0718880A2 (pt) 2013-12-17
RU2009124460A (ru) 2011-01-10
AU2007327472A1 (en) 2008-06-05
CN101563099A (zh) 2009-10-21
JP2010511020A (ja) 2010-04-08
KR20090085122A (ko) 2009-08-06
FI20065757A (sv) 2008-05-29

Similar Documents

Publication Publication Date Title
FI20065757A0 (sv) Användning av beta-laktamas
CY2020025I2 (el) Αναστολεις βητα-λακταμασων
ATE531720T1 (de) Aza-benzofuranylverbindungen und anwendungsverfahren dafür
NO345061B1 (no) Anvendelse av DPP-IV inhibitorer
DOP2007000084A (es) Derivados de dihidropirazolopirimidinona
DK1940839T3 (da) Pyridopyrimidione Inhibitors of P13Ka
CR10562A (es) Nuevos derivados de piridazina
CR10815A (es) Nuevos derivados de isoquinolina e isoquinolinona sustituidos
ITMI20060943A1 (it) Nessuno
CR10809A (es) Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona
BRPI0812087A2 (pt) Processos de formação de pré-formas de silenciosos
FI20065834A0 (sv) Slaganordning
NO20083139L (no) Anvendelse av hyllebærekstrakt
SE0601589L (sv) Administrering av opioider
FI20065478L (sv) Biosensor
BRPI0914787A2 (pt) antibióticos trinem e inibidores de beta-lactamases
FI20065360A (sv) Förbättrad användning av parallella mediaflöden
NO20053517L (no) Anvendelse av lipidsenkende midler
FI20060324A (sv) Begränsning av tjänsteanvändning
ITCA20060011A1 (it) Marmellata di pompia
UA14849S (uk) Комплект піктограм
UA13850S (uk) Набір столових приборів
UA12593S (uk) Стела-цінник світива
FI20060668A0 (sv) Slaganordning
DOP2006000083A (es) Compuestos novedosos de derivados de aminosulfonilo

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119678

Country of ref document: FI

MM Patent lapsed